Clobetasol Propionateemollient Formulation
Clobetasol Propionateemollient Formulation Uses, Dosage, Side Effects, Food Interaction and all others data.
Clobetasol Propionateemollient Formulation is under investigation for the treatment of Scleroderma. Clobetasol Propionateemollient Formulation has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
| Trade Name | Clobetasol Propionateemollient Formulation |
| Availability | Prescription only |
| Generic | Clobetasol |
| Clobetasol Other Names | Clobetasol |
| Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
| Type | |
| Formula | C22H28ClFO4 |
| Weight | Average: 410.907 Monoisotopic: 410.166015296 |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | USA |
| Last Updated: | September 19, 2023 at 7:00 am |
Clobetasol Propionateemollient Formulation Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
Innovators Monograph
You find simplified version here Clobetasol Propionateemollient Formulation
